Filing Details

Accession Number:
0001551986-18-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-29 20:00:51
Reporting Period:
2018-11-29
Accepted Time:
2018-11-29 20:00:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551986 Innovate Biopharmaceuticals Inc. INNT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1721749 P. Christopher Prior C/O Innovate Biopharmaceuticals, Inc.,
8480 Honeycutt Road, Suite 120
Raleigh NC 27615
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-29 5,000 $2.75 7,009 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct